The aim of the meeting is to provide an update to the ELIXIR Toxicology Community on the implementation study, as it was submitted on 14 July,  and discuss collaboration with the Partnership for the Assessment of Risks from Chemicals (PARC, eu-parc.eu) and other toxicology projects, for leveraging the FAIRification of toxicology data and ELIXIR life sciences infrastructure for toxicology.

The meeting will facilitate knowledge sharing, address concerns, gather input, and foster collaboration to achieve the project's objectives. It also aims to explore synergies between ELIXIR and PARC. Overall, the meeting aims to strengthen the ELIXIR Toxicology Community, advance the implementation study, and promote FAIR practices in toxicology data management.

This meeting has a limit of in-person attendees, with no-limit on virtual participant numbers. 

Details regarding funding and reimbursement will be shared after registration. 

Please do not book any travel till after you have been notified.

Additional Registration information

Please note, if you have selected to attend the face to face meeting, this option is limited to first come first served basis. All registrants will be informed via email regarding their registration. Please do not book any travel till after you have been notified.  

Travel and venue

Venue: Campus Brussels, Maastricht University, Tervurenlaan 153, 1150, Sint-Pieters-Woluwe, Belgium, and online via Zoom (via ELIXIR Hub Zoom Account).

Best is to travel to Brussel Central Station, then take metro line 1, to Montgomery metro station (direction Stockel), exit the metro station in south/south west ward direction.

Public transportation by train: https://www.belgiantrain.be/en.

Once notified of your F2F attendance you will be expected to make your own travel and accommodation arrangements to the venue, reimbursement information will be shared with invited attendees after their successful registration. 

F2F registration deadline: 1 September  

Virtual registration deadline: 19 September

Contacts: 

Clare Garrard  [email protected] 

Katharina Heil [email protected]